Keywords: major, investment, sanofi, pasteur, part, french, drug
Major investment for Sanofi Pasteur
Article | 23 April 2007
Sanofi Pasteur, a part of the French drug giant Sanofi-Aventis, expects to have completed investment of 200.0 million euros ($270.9 million) by 2009 ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Neovacs moving forward in rheumatoid arthritis, say analysts
